Skip to main content

TERUMO GLOBAL

Search

Select Region

Show — Select Region Hide — Select Region

- Regions/Countries
  - - Europe
    - Latin America
      - Mexico
        
        Brazil
        
        Colombia
        
        Chile and Argentina
        
        Latin America
  - - Asia Pacific
    - Australia
    - Korea
    - Vietnam
    - China
    - India
- Global Business website

About Terumo
About Terumo
Dear Stakeholders
Terumo Group Identity
Terumo Group Code of Conduct
Corporate Profile
Corporate Governance
Compliance
Procurement Activity
Regulations and Standards
Directors and Executive Officers
History
Our Stories
Terumo's Response to COVID-19
Business Overview
Business Overview
TIS Division (Terumo Interventional Systems)
Neurovascular Division (MicroVention)
Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division
Vascular Graft Division (Terumo Aortic)
Hospital Care Solutions Division / Life Care Solutions Division
Pharmaceutical Solutions Division
Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
Sustainability
Sustainability
Sustainability News
Message from Top Management
Sustainability at the Terumo Group
Resolving Healthcare Challenges
Creating a Diverse and Inclusive Workplace
Reducing Environmental Footprint
Serving Our Communities
Report Library
GRI Standards Index
Technology
Technology
Basic Information
Basic Information Top
Research and Development
Production and Supply
Intellectual Property
Terumo Fellows
Stories - Our Technologies
Investors
Investors
Management Policy
Management Policy
Top Management Message
Business Risks
Disclaimer
IR Policy
Financial Highlights
IR Library
IR Library
Financial Statements
Presentations
Consolidated Financial Statements
Terumo Reports
IR Events
Shareholders & Stock
Shareholders Meeting
Stock Information
Shareholder Return
Credit Ratings and Corporate Bond
Analyst Coverage
Articles of Incorporation
Site Quote
IR Inquiries
News
News
May 25, 2022
Corporate
Terumo Blood and Cell Technologies Inaugurates Second Manufacturing Facility in Colorado
May 17, 2022
Corporate
Terumo Pharmaceutical Solutions Offers Pre-Fillable Syringe Solutions for Demanding Low Dose Applications Such as Ophthalmic
May 16, 2022
Corporate
Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan
Adjunctive use of Blood Glucose Meter Principally Not Required
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Global Network
Global Network
Japan
North America
South America
Europe, Middle East and Africa
Greater China
Asia and Pacific

Breadcrumb

Home
News

News

Move to top

Top

Refining Searches

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

Corporate

Financial

November 05, 2015

Financial

Terumo Revises Upward Interim Dividend and Year-End Dividend Forecast for the Fiscal Year Ending March 31, 2016 (PDF 17.28 KB)
September 24, 2015

Financial

Revision to First-Half and Full-Year Results Forecast for FY2015 (PDF 59.8 KB)
September 18, 2015

Corporate

Terumo Receives Approval for the Manufacturer and Sale of its HeartSheet Autologous Skeletal Myoblast Sheets in Japan
September 09, 2015

Corporate

Terumo Invests in Quirem Medical, Focusing on Interventional Oncology Field
September 02, 2015

Corporate

Terumo's Autologous Skeletal Myoblast Sheets Are the First to Be Approved as a Cellular or Tissue-based Products in Japan by a Council of the Ministry of Health, Labour and Welfare
August 12, 2015

Financial

Notice Concerning Acquisition Results of the Company's Own Shares by ToSTNeT-3 (PDF 63.66 KB)
August 11, 2015

Financial

Notice Concerning Acquisition of the Company's Own Shares through ToSTNeT-3 (PDF 21.89 KB)
August 10, 2015

Corporate

Terumo Receives Approval for the Manufacturer and Sale of its Ultimaster Drug-Eluting Coronary Stent in Japan
August 07, 2015

Financial

Notice Concerning the Issuance of Stock Option (Share Warrants) (PDF 84.38 KB)
August 04, 2015

Financial

Notice Concerning Acquisition of the Company's Own Shares(Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 60.58 KB)
June 24, 2015

Financial

Notice regarding the appointment of Independent Committee Members for the "Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures" (PDF 67.88 KB)
May 28, 2015

Corporate

Terumo to Support Relief Efforts Following Nepal Earthquake
May 19, 2015

Corporate

Terumo Announces CE Mark Clearance for Bioresorbable Scaffold Developed by Arterial Remodeling Technologies (ART)
May 08, 2015

Corporate

Notice Concerning Members of the Board of Directors after the Transition to a Company with an Audit/Supervisory Committee (PDF 56.07 KB)
May 08, 2015

Financial

Notice Regarding Dividend for the Fiscal Year Ended March 31, 2015 (PDF 17.43 KB)
April 23, 2015

Corporate

Notice Concerning Partial Amendment of the Articles of Incorporation (PDF 67.5 KB)
April 23, 2015

Corporate

Notice Concerning Transition to a Company with an Audit/Supervisory Committee (PDF 81.2 KB)
April 17, 2015

Corporate

Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant by U.S. Food & Drug Administration (FDA)
April 10, 2015

Corporate

Daiichi Sankyo and Terumo Announce Application in Japan for Manufacturing and Sales Approval of Intradermal Seasonal Influenza Vaccine
April 06, 2015

Corporate

Terumo and Olympus Expand Interventional System Business Partnership in the U.S. to Cover Urology and Gastroenterology
March 27, 2015

Corporate

FAMHP advises patients to not suspend nor stop any treatments
March 23, 2015

Corporate

Terumo Europe responds to broadcast EenVandaag Injection needles pose no health risks for patients
February 12, 2015

Corporate

Terumo Establishes a New R&D Center for Interventional Business in Southern California, US to Accelerate Worldwide Growth of Interventional Therapeutic Area
February 03, 2015

Financial

Notice Concerning Acquisition of the Company's Own Shares (Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 73.77 KB)

Pagination

Previous page
Current page1
Next page

Footer Menu

Show — Footer Menu Hide — Footer Menu

- Investors
- News
  - - News
    - Press Inquiries
- Global Network

About Terumo
Business Overview
Sustainability
Technology
Investors
News
Global Network

Footer

Show — Footer Hide — Footer

Terms and Conditions of Use
Privacy Policy
Cookie Policy
Cookie Settings
Social Media Policy
Site Map

Copyright © 2022 Terumo Corporation, All Rights Reserved.